Product consistency and lack of standards has been identified as possibly the largest challenge facing the field of regenerative medicine. In order to begin to address these issues, a workshop, "Strategies to Achieve Measurement Assurance for Cell Therapy Products," was convened at the National Institutes of Standards & Technology (NIST) May 11-12, 2015.
展开▼
